Pura Vida Investments, LLC Mirati Therapeutics, Inc. Call Options Transaction History

Pura Vida Investments, LLC

  • $140 Million
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$70.76 - $128.86 $3.54 Million - $6.44 Million
-50,000 Closed
0 $0
Q3 2019

Feb 12, 2021
BUY
$77.91 - $109.6 $3.86 Million - $5.43 Million
49,500 Added 9900.0%
50,000 $3.9 Million
Q3 2019

Nov 14, 2019
BUY
$77.91 - $109.6 $38,955 - $54,800
500 New
500 $48,000

Others Institutions Holding MRTX

# of Institutions
19
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email